EDELMAN JOSEPH Insider Trading Activity

Average Profitability
7.77%
Insider Buys Quantity
97
Insider Buys Sum
$151.82M
Insider Sells Quantity
9
Insider Sells Sum
$16.17M

Insider Activity of EDELMAN JOSEPH

Biography of EDELMAN JOSEPH

No biography is available at this moment.

2022-08-09PurchaseAldeyra Therapeutics, Inc.
ALDX
15,000
0.027%
$7.85$117,750-4.83%
2022-08-08PurchaseAldeyra Therapeutics, Inc.
ALDX
97,000
0.1669%
$7.24$702,280-1.53%
2022-08-05PurchaseAldeyra Therapeutics, Inc.
ALDX
141,000
0.2422%
$6.95$979,950+2.46%
2022-08-04PurchaseAldeyra Therapeutics, Inc.
ALDX
95,100
0.1609%
$6.17$586,767+13.62%
2022-08-03PurchaseAldeyra Therapeutics, Inc.
ALDX
100,000
0.1722%
$5.84$584,000+21.9%
2022-08-02PurchaseAldeyra Therapeutics, Inc.
ALDX
412,406
0.6992%
$5.59$2.31M+24.82%
2022-08-01PurchaseAldeyra Therapeutics, Inc.
ALDX
144,185
0.2447%
$5.05$728,134+38.31%
2022-07-29PurchaseAldeyra Therapeutics, Inc.
ALDX
222,123
0.3792%
$5.03$1.12M+39.38%
2022-07-28PurchaseAldeyra Therapeutics, Inc.
ALDX
119,392
0.2042%
$5.00$596,960+40.4%
2022-07-05PurchaseVerrica Pharmaceuticals Inc.
VRCA
1.43M
2.9773%
$2.10$3M+61.6%
2008-11-19SaleXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
9.6M
6.44%
$0.15$1.47M+40%
2008-11-18SaleXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
30.45M
19.0502%
$0.14$4.34M+7.69%
2008-06-10PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
51,000
0.7232%
$3.23$164,730-92.26%
2008-06-09PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
33,600
0.4956%
$3.36$112,896-92.63%
2008-06-06PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
100,000
1.5059%
$3.43$343,000-92.84%
2008-06-05PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
300,000
4.2453%
$3.22$967,000-92.75%
2008-06-04PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
25,000
0.3282%
$2.99$74,750-91.61%
2008-06-03PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
400,730
5.3307%
$3.03$1.21M-91.75%
2008-05-02PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
50,000
0.8517%
$3.88$194,000-40.41%
2008-05-01PurchaseXTL Biopharmaceuticals Ltd.
XTLB
10 percent owner
105,000
1.7287%
$3.75$393,750-40.21%
Total: 103
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.